| Adjuvants are key factors for the development of future vaccines: lessons from the Finlay adjuvant platform O Pérez, B Romeu, O Cabrera, E González, A Batista-Duharte, A Labrada, ... Frontiers in immunology 4, 407, 2013 | 79 | 2013 |
| New vaccines require potent adjuvants like AFPL1 and AFCo1 O Pérez, M Lastre, O Cabrera, J Del Campo, G Bracho, M Cuello, ... Scandinavian Journal of Immunology 66 (2‐3), 271-277, 2007 | 79 | 2007 |
| Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations O Pérez, A Batista-Duharte, E González, C Zayas, J Balboa, M Cuello, ... Brazilian Journal of Medical and Biological Research 45, 681-692, 2012 | 75 | 2012 |
| Mucosal approaches in Neisseria vaccinology J Balboa, B Romeu, M Baró, C Campa, MI Lantero, G Sierra, MA Galindo, ... VacciMonitor 18 (2), 53-55, 2009 | 48 | 2009 |
| Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses J Del Campo, C Zayas, B Romeu, R Acevedo, E González, G Bracho, ... Methods 49 (4), 301-308, 2009 | 45 | 2009 |
| Estudio bibliométrico de la producción científica de VacciMonitor (2000-2013) DF Arencibia-Arrebola, V Betancourt-López, N González-Alfalla, ... VacciMonitor 23 (2), 41-48, 2014 | 28 | 2014 |
| Natural Neisseria derive proteoliposome and cochleate as potent vaccine adjuvants O Pérez, M Lastre, G Bracho, J Del Campo, C Zayas, R Acevedo, D Gil, ... Pharmacology online 3, 762-4, 2006 | 19 | 2006 |
| New meningococcal C polysaccharide-tetanus toxoid conjugate: Physico-chemical and immunological characterization M Cuello, O Cabrera, I Martinez, JM Del Campo, MA Camaraza, ... Vaccine 25 (10), 1798-1805, 2007 | 14 | 2007 |
| Los biomodelos aplicados al desarrollo de vacunas y sueros en el Instituto Finlay JF Infante, S Sifontes, G Sierra, C Campa, M Fariñas, R Oliva, V PÉREZ, ... Animales de Experimentación 3 (3), 16-23, 1998 | 13 | 1998 |
| Preparation and evaluation of Vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide–tetanus toxoid conjugates O Cabrera, ME Martínez, M Cuello, CR Soto, T Valmaseda, B Cedré, ... Vaccine 24, S74-S75, 2006 | 12 | 2006 |
| Evaluación de los Anticuerpos Monoclonales anti-polisacárido capsular de Neisseria meningitidis serogrupos A, C, Y, W y X para su uso en los ensayos de identidad E González-Aznar, O Otero-Alfaro, O Cabrera-Blanco, ... VacciMonitor 24 (2), 64-70, 2015 | 11 | 2015 |
| AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses B Romeu, E González, C Zayas, JD Campo, R Acevedo, M Cuello, ... Scandinavian journal of infectious diseases 43 (10), 809-813, 2011 | 11 | 2011 |
| Mucosal and systemic immune responses induced by a single time vaccination strategy in mice E González Aznar, B Romeu, M Lastre, C Zayas, M Cuello, O Cabrera, ... Canadian Journal of Microbiology 61 (8), 531-538, 2015 | 10 | 2015 |
| Inmunopotenciadores para la acuicultura R Pérez, B Romeu, M Lastre, Y Morales, O Cabrera, L Reyes, E González, ... VacciMonitor 23 (1), 24-31, 2014 | 10 | 2014 |
| Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B C Zayas, D González, R Acevedo, J Del Campo, M Lastre, E González, ... BMC immunology 14, 1-5, 2013 | 10 | 2013 |
| Single-time vaccines OGP Martin, EA Gonzalez, BA Romeu, JMDC Alonso, RG Acevedo, ... US Patent App. 13/130,146, 2011 | 9 | 2011 |
| Mucosal and systemic immune response against Neisseria meningitidis B induced by single time vaccination strategy N Nuñez, Y Valdez, M Fariñas, O Pérez, E González, B Romeu, ... VacciMonitor 18 (2), 73-75, 2009 | 9 | 2009 |
| New method for obtaining conjugated vaccines O Cabrera, M Cuello, CR Soto, ME Martínez, JM del Campo, O Pérez, ... Vaccine 24, S76-S78, 2006 | 9 | 2006 |
| Nasal immunization with AFCo1 induces immune response to N. gonorrhoea in mice B Romeu, K Thörn, M Lindqvist, J Persson, AM Harandi, O Pérez, ... Vaccimonitor 18 (2), 76-78, 2009 | 8 | 2009 |
| Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid JA Balboa, M Cuello, O Cabrera, J Del Campo, M Lastre, D Gil, ... Vaccine 24, S63-S64, 2006 | 8 | 2006 |